Workday just delivered a 14% week, with the stock closing Friday at $146.19 — but the shorts who built up through early May have barely moved, setting up an unusual tension between price action and positioning.
The earnings print on May 21 landed with a modest positive reaction, up just over 1% on the day and 2.7% over five days. That muted initial response belies what happened next. The stock accelerated through the week, lifted by a broad enterprise software rally that swept up close peers too — NOW gained 25% on the week, TEAM jumped 31%, and PD surged over 41%. Workday caught a meaningful share of that tide, but it remained a relative laggard in the group.
The positioning picture is striking precisely because the rally happened over the top of an elevated short base. Short interest holds at 12.7% of the free float — roughly 27.6 million shares — down less than 1% on the week. That short position nearly doubled in late April and early May, jumping from around 19–20 million shares to over 27 million in the space of a few sessions around May 8–11. That build is still almost entirely intact. The ORTEX short score has ticked slightly lower this week, from 59.5 to 58.7, but remains firmly in elevated territory. Borrow is cheap at 0.51% and the lending pool is wide open — availability runs near 592%, meaning supply for new shorts is plentiful — so there is no squeeze dynamic at work. The shorts are underwater, but not squeezed.
Options positioning has eased from pre-earnings defensiveness. Before the May 21 print, the put/call ratio had spiked to the high 0.86s; it has since settled back to 0.84, sitting about one standard deviation above the 20-day average of 0.78. That is modestly cautious rather than alarmed — hedgers have pulled back some protection after the event passed, but they haven't fully reverted to the bullish call-heavy positioning seen in mid-May. The 52-week PCR range runs from 0.60 to 1.65, so current levels sit near the middle, tilted slightly defensive.
The Street response to earnings was a clear net positive, but divided. Bulls lifted targets: Wells Fargo moved to $185 and KeyBanc raised to $158, both maintaining positive ratings. Several neutral-rated houses — UBS, Jefferies, Piper Sandler — also nudged targets higher but stayed on the sidelines on rating. The drag came from Goldman Sachs, where Kash Rangan maintained his Neutral stance but cut his target sharply from $206 to $151 — a notable reset that lands the Goldman target below the current price of $146. With the stock now trading at $146 against a consensus mean target of $171, the implied analyst upside is around 17%. The 35 analysts covering the stock are roughly split between buy/outperform (24) and hold (17), a distribution that reflects genuine uncertainty about whether the AI disruption narrative will suppress Workday's core HCM and financials growth. EPS momentum at the 65th percentile and a dividend score at 72 suggest the underlying financial profile is respectable; the bear case rests on whether AI-native competitors can erode the enterprise install base faster than new product lines — including recent acquisitions of Sana ITSM Agent and Sana Travel Agent — can replace that revenue.
On the institutional side, founder David Duffield remains the dominant holder at 15.2% of shares. The last insider filings in April showed cluster selling from Duffield, the CFO, and other executives — transactions executed at prices well below the current $146 level, mostly in the $111–128 range. None of the disclosed trades carry high significance scores, suggesting routine scheduled selling rather than conviction moves. Hotchkis and Wiley added nearly 3.9 million shares in Q1, and First Eagle built a meaningful new position of 3.3 million shares, indicating that value-oriented managers see the de-rated multiple as attractive. The PE multiple has compressed sharply from above 100 six months ago to around 11x now, with EV/EBITDA at 8.1x — a significant re-rating that frames why value buyers have been stepping in.
The next earnings event is scheduled for June 16. With short interest still elevated, a $25 spread between the Goldman target and the rest of the Street, and a PCR that remains above its recent average, whether the post-earnings short book starts to unwind or digs in further will be the defining dynamic heading into that next print.
See the live data behind this article on ORTEX.
Open WDAY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
